Ingevity Stock Seen 14% Undervalued Amid Portfolio Reshaping

Analysts estimate Ingevity stock is 14% undervalued at $73.41 versus a fair value of $85.50, driven by a strategic shift toward higher-growth specialty chemicals. However, a price-to-sales ratio above the industry average indicates potential valuation risks.